ENDOTHELION Study Group: Effect of Bosentan in NAION Patients

NCT02377271 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Optic Neuropathy

Interventions

DRUG: bosentan
DRUG: placebo

Sponsor

University Hospital, Grenoble